Scientists from UrFU and UB RAS have developed a new platform for rapid diagnostics of viral and bacterial diseases. It can also be used to determine the level of certain antibiotics in a patient's body.
Its counterparts are based on biological substances - antibodies, antigens, proteins, which have a shelf life and special storage requirements.
The Ural innovative system is based on a highly stable chemical reagent, unique molecules. They were developed by specialists from UrFU and the Postovsky Institute of Organic Synthesis of the UB RAS.
The shelf life of such a chemical base reaches at least a year, its synthesis is cheaper, and the result is more reliable.
When working, the test system quickly detects the presence of an infectious disease pathogen in a patient - viral (influenza, measles, Coxsackie) or bacterial in nature. This saves the doctor's time and the patient's money on examinations.
The test system bacteria are very sensitive and give a reliable result in just 5 minutes. To do this, you need to take a swab from the nasopharynx, place it in a solution and drip it onto the sensor. The result will appear on the computer monitor.
The peculiarity of the development is its chemical basis - the ability of original organic molecules to selectively interact with viral proteins and some antibiotics. This principle of operation ensures high stability of the device, and is also original - there are no such devices in the world.
Scientists have been working on the test system since 2020, and it has already been successfully tested. The scientists have found an industrial partner, and the first sample for industrial production is expected in the fall of 2024. The platform may enter the wider market in two years.
